International Journal of Radiation Oncology * Biology * Physics
Volume 69, Issue 4 , Pages 1238-1245 , 15 November 2007

Assessment of Tumor Response to the Vascular Disrupting Agents 5,6-Dimethylxanthenone-4-Acetic Acid or Combretastatin-A4-Phosphate by Intrinsic Susceptibility Magnetic Resonance Imaging

  • Lesley D. McPhail, Ph.D.

      Affiliations

    • CRUK Clinical Magnetic Resonance Research Group, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
    • Department of Basic Medical Sciences, St. George's, University of London, London, United Kingdom
    • Corresponding Author InformationReprint requests to: Lesley D. McPhail, Ph.D., Institute of Cancer Research, 15 Cotswold Road, Belmont, Sutton, Surrey SM2 5NG, United Kingdom. Tel: (+44) (0) 20-8661-3738; Fax: (+44) (0) 20-8661-0846
  • ,
  • John R. Griffiths, D.Phil.

      Affiliations

    • Department of Basic Medical Sciences, St. George's, University of London, London, United Kingdom
  • ,
  • Simon P. Robinson, Ph.D.

      Affiliations

    • CRUK Clinical Magnetic Resonance Research Group, The Institute of Cancer Research, Sutton, Surrey, United Kingdom
    • Department of Basic Medical Sciences, St. George's, University of London, London, United Kingdom

Received 21 June 2007 ,Revised 15 August 2007 ,Accepted 16 August 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 J. R. Griffith's present address is CRUK Cambridge Research Institute, Robinson Way, Cambridge CB2 0RE, United Kingdom.

 Supported by Cancer Research UK, Grant CI 6412/A6269 and The Royal Society. S.P.R. is the recipient of a Royal Society University Research Fellowship.

 Conflict of interest: none.

PII: S0360-3016(07)03910-7

doi: 10.1016/j.ijrobp.2007.08.025

International Journal of Radiation Oncology * Biology * Physics
Volume 69, Issue 4 , Pages 1238-1245 , 15 November 2007